Characterization of lectin-mediated brain uptake of HIV-1 GP120

Journal of Neuroscience Research

Volumn 54, Issue 4, 1998, Pages 522-529

  Banks, William A ^a,b,e   Kastin, Abba J ^c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

Adsorptive endocytosis; Agglutinin; AIDS; AIDS dementia complex; Blood brain barrier; Glycoprotein; gp120; HIV; Lectin

Indexed keywords

AGGLUTININ; GLYCOPROTEIN GP 120; LECTIN; N ACETYLGLUCOSAMINE; WHEAT GERM AGGLUTININ;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; VIRUS CELL INTERACTION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; ENDOCYTOSIS; HALF-LIFE; HIV ENVELOPE PROTEIN GP120; INJECTIONS, INTRAVENOUS; KINETICS; LECTINS; LIVER; MALE; MICE; MICE, INBRED ICR; PERMEABILITY; PLASMA; RICIN; SPLEEN; TISSUE DISTRIBUTION; WHEAT GERM AGGLUTININS;

EID: 0032533375     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19981115)54:4<522::AID-JNR9>3.0.CO;2-O     Document Type: Article

References (51)

1. Advokat C, Gulati A (1991): Spinal transection reduces both spinal antinociception and CNS concentration of systemically administered morphine in rats. Brain Res 555:251-258.
2. Balzarini J, Neyts J, Schols D, Hosoya M, Van Damme E, Peumans W, De Clercq E (1992): The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helteborin and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro. Antiviral Res 18:191-207.
3. Banks WA, Akerstrom V, Kastin AJ (1998): Adsorptive endocytosis mediates the passage of HIV-1 across the blood-brain barrier: evidence for a post-internalization co-receptor. J Cell Sci 111:533-540.
4. Banks WA, Broadwell RD (1994): Blood to brain and brain to blood passage of native horseradish peroxidase, wheat germ agglutinin and albumin: pharmacokinetic and morphological assessments. J Neurochem 62:2404-2419.
5. Banks WA, Kastin AJ (1983): Aluminium increases permeability of the blood-brain barrier to labeled DSIP and β-endorphin: possible implications for senile and dialysis dementia. Lancet ii:1227-1229.
6. Banks WA, Kastin AJ (1991): Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci 48:PL117-PL121.
7. Banks WA, Kastin AJ (1993): Measurement of transport of cytokines across the blood-brain barrier. In DeSouza EB (ed): "Methods in Neurosciences, Vol 16." San Diego: Academic Press, pp 67-77.
8. Banks WA, Kastin AJ (1994): Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine. Peptides 15:23-29.
9. Banks WA, Kastin AJ, Akerstrom V (1997): HIV-1 protein gp120 crosses the blood-brain barrier: role of adsorptive endocytosis. Life Sci 61:PL119-PL125.
10. Banks WA, Kastin AJ, Fasold MB (1988): Differential effect of aluminum on the blood-brain barrier transport of peptides, technetium and albumin. J Pharmacol Exp Ther 244:579-585.
11. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM (1996): Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305-311.
12. Blasberg RG, Fenstermacher JD, Patlak CS (1983): Transport of α-aminoisobutyric acid across brain capillary and cellular membranes. J Cereb Blood Flow Metab 3:8-32.
13. Bourinbaiar AS, Phillips DM (1991): Transmission of human immunodeficiency virus from monocytes to epithelia. J Acquired Immune Defic Syndr 4:56-63.
14. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR, Pert CB (1988): Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335:639-642.
15. Broadwell RD (1989): Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal. Acta Neuropathol: 79:117-128.
16. Broadwell RD, Balin BJ, Salcman M (1988): Transcytotic pathway for blood-borne protein through the blood-brain barrier. Proc Natl Acad Sci USA 85:632-636.
17. Broadwell RD, Sofroniew MV (1993): Serum proteins bypass the blood-brain barrier for extracellular entry to the central nervous system. Exp Neurol 120:245-263.
18. Busso M, Thornthwaite J, Resnick L (1991): HIV-induced syncytium formation requires the formation of conjugates between virus-infected and uninfected T-cells in vitro. AIDS 5:1425-1432.
19. Chou S, Dix RD (1989): Viral infections and the blood-brain barrier. In Neuwelt EA (ed): "Implications of the Blood-Brain Barrier and Its Manipulation, Vol. 2: Clinical Aspects." New York: Plenum Publishing, pp 449-468.
20. Corbeau P, Haran M, Binz H, Devaux C (1994): Jacalin, a lectin with anti-HIV-1 properties, and HIV-1 gp120 envelope protein interact with distinct regions of the CD4 molecule. Mol Immunol 31:569-575.
21. Davson H, Segal MB (1996): Morphological aspects of the barriers. In "Physiology of the CSF and Blood-Brain Barriers." Boca Raton, FL: CRC Press, pp 93-192.1
22. Davson H, Segal MB (1996): Special aspects of the blood-brain barrier. In Anonymous: "Physiology of the CSF and Blood-Brain Barriers." Boca Raton: CRC Press, pp 303-485.
23. Davson H, Welch K, Segal MB (1987): Morphological aspects of the barriers. In Anonymous: "The Physiology and Pathophysiology of the Cerebrospinal Fluid." Edinburgh: Churchill Livingstone, pp 105-188.
24. Dawson VL, Dawson TM, Uhl GR, Snyder SH (1993): Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 90:3256-3259.
25. Gattegno L, Ramdani A, Jouault T, Saffar L, Gluckman JC (1992): Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1). AIDS Res Hum Retroviruses 8:27-37.
26. Glowa JR, Panlilio LV, Brenneman DE, Gozes I, Fridkin M, Hill JM (1992): Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Res 570:49-53.
27. Gram GJ, Hansen J-ES (1998): Characterization of HIV gp120 envelope glycoprotein by lectin analysis. In Rhodes JM, Milton JD (eds): "Lectin Methods and Protocols." Towtowa, NJ: Humana Press, pp 167-174.
28. Gutierrez EG, Banks WA, Kastin AJ (1993): Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol. 47:169-176.
29. Hammar L, Hirsch I, Machado A, De Mareuil J, Baillon J, Chermann JC (1994): Lectin effects on HIV-1 infectivity. Ann NY Acad Sci 724:166-169.
30. Harouse JM, Wroblewska Z, Laughlin MA, Hickey WF, Schonwetter BS, Gonzalez-Scarano F (1989): Human choroid plexus cells can be latently infected with human immunodeficiency virus. Ann Neurol 25:406-411.
31. Hill JM, Mervis RF, Avidor R, Moody TW, Brenneman DE (1993): HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res 603:222-233.
32. Hurwitz AA, Berman JW, Lyman WD (1994): The role of the blood-brain barrier in HIV infection of the central nervous system. Adv Neuroimmunol. 4:249-256.
33. Kinne RW, Becker W, Koscheck T, Kuhlmann J, Sharkey RM, Behr T, Palombo-Kinne E, Goldenberg DM, Wolf F, Emmrich F (1995): Rat adjuvant arthritis: imaging with technetium-99m-ant-CD4 Fab' fragments. J Nucl Med 36:2268-2275.
34. Lipton SA (1991): HIV-related neurotoxicity. Brain Pathol 1:193-199.
35. Marsh M (1984): The entry of enveloped viruses into cells by endocytosis. Biochem J 218:1-10.
36. Masereeuw R, Jaehde U, Langemeijer MWE, De Boer AG, Breimer DD (1994): In vivo and in vivo transport of zidovudine (AZT): across the blood-brain barrier and the effects of transport inhibitors. Pharm Res 11:324-330.
37. Moses AV, Bloom FE, Pauza CD, Nelson JA (1993): Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc Natl Acad Sci USA 90:10474-10478.
38. Moses AV, Nelson JA (1994): HIV infection of human brain capillary endothelial cells - Implications for AIDS dementia. Adv Neuroimmunol 4:239-247.
39. Oh SK, Cruikshank WW, Raina J, Blanchard GC, Adler WH, Walker J, Kornfeld H (1992): Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr 5:251-256.
40. Patlak CS, Blasberg RG, Fenstermacher JD (1983): Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:1-7.
41. Rapoport SI (1976): Blood Brain Barrier in Physiology and Medicine. New York: Raven Press.
42. Raub TJ, Audus KL (1990): Adsorptive endocytosis and membrane recycling by cultured primary bovine brain microvessel endothelial cell monolayers. J Cell Sci 97:127-138.
43. 111In-labeled anti-CD4 monoclonal antibody. Proc Natl Acad Sci USA 93:7460-7463.
44. Sagnelli E, Filippini P, Guarino M, Lapenta C, Marrocco C, Messina V, Aprea L, Piccinino R, Scolastico C, Panico L, et al. (1994): Detection of HIV antigens in immunocomplexes (ICs): in seronegative subjects at risk of HIV infection. Int Conf AIDS 8:35 (Abstract).
45. Taimi M, Dornand J, Nicolas M, Marti J, Favero J (1994): Involvement of CD4 in interleukin-6 secretion by U937 monocytic cells stimulated with the lectin jacalin. J Leukocyte Biol 55:214-220.
46. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L (1994): Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188-193.
47. Villegas JC, Broadwell RD (1993): Transcytosis of protein through the mammalian cerebral epithelium and endothelium: II. Adsorptive transcytosis of WGA-HRP and the blood-brain and brain-blood barriers. J Neurocytol 22:67-80.
48. Vitkovic L, da Cunha A, Tyor WR (1994): Cytokine expression and pathogenesis in AIDS brain. In Price RW, Perry SW (eds): "HIV, AIDS and the Brain." New York: Raven Press, pp 203-221.
49. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA (1986): Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83:7089-7093.
50. Yang W-X, Terasaki T, Shiroki K, Ohka S, Aoki J, Tanabe S, Nomura T, Terada E, Sugiyama Y, Nomoto A (1997): Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology (in press).
51. Zatta PF, Zanoni S, Favarato M (1994): Lectin histochemistry of the brain cortex in Alzheimer's disease. In Nicolini M, Zatta PF (eds): "Glycobiology and the Brain." Oxford: Pergamon Press, pp 141-153.